# OnCo record paper-select-lenvatinib-nejm-2015 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-select-lenvatinib-nejm-2015/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-select-lenvatinib-nejm-2015" ;
  schema:name "SELECT: lenvatinib versus placebo in radioiodine-refractory differentiated thyroid cancer"@en ;
  schema:description "The multikinase inhibitor lenvatinib delayed progression by almost fifteen months compared with placebo in iodine-refractory differentiated thyroid cancer and shrank tumours in two thirds of patients, becoming the preferred drug for this disease."@en ;
  schema:url <https://onco.cc/key-papers/paper-select-lenvatinib-nejm-2015/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa1406470>, <https://pubmed.ncbi.nlm.nih.gov/25671254/> ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa1406470> ;
  schema:datePublished "2015"^^xsd:gYear ;
  schema:author "Schlumberger M, Tahara M, Wirth LJ, et al." ;
  onco:cancers <https://onco.cc/cancers/follicular-thyroid-cancer/>, <https://onco.cc/cancers/papillary-thyroid-cancer/> ;
  onco:drugs <https://onco.cc/drugs/lenvatinib/> ;
  onco:trials <https://onco.cc/trials/select-lenvatinib/> ;
  onco:journals <https://onco.cc/journals/nejm/> .
